Transformation of curcumin from food additive to multifunctional medicine: Nanotechnology bridging the gap

Current Drug Discovery Technologies

Volumn 11, Issue 3, 2014, Pages 197-213

  Ahmad, Mohammad Zaki ^a   Akhter, Shabib ^a   Mohsin, Nehal ^a   Abdel Wahab, Basel A ^a   Ahmad, Javed ^b   Warsi, Musarrat Husain ^b   Rahman, Mahfoozur ^b   Mallick, Neha ^b   Ahmad, Farhan Jalees ^b  

^a NAJRAN UNIVERSITY   (Saudi Arabia)

^b HAMDARD UNIVERSITY   (India)

Author keywords

Anti inflammatory; Anticancer; Bioavailability; Curcumin; Curcumin nanocarriers; Nanocurcumin; Nanoparticles; Neuroprotective; Solid lipid nanoparticles

Indexed keywords

CURCUMIN; FOOD ADDITIVE; LIPOSOME; SOLID LIPID NANOPARTICLE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; NANOPARTICLE;

ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BIOAVAILABILITY; BLOOD LEVEL; CARDIOVASCULAR DISEASE; DRUG METABOLISM; HUMAN; LIPOPHILICITY; MICELLE; NANOEMULSION; NANOMEDICINE; NANOTECHNOLOGY; NEUROPROTECTION; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; SOLUBILITY; WOUND HEALING; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; NEOPLASMS; PROCEDURES; TRENDS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CURCUMIN; DRUG DELIVERY SYSTEMS; FOOD ADDITIVES; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS;

EID: 84925664026     PISSN: 15701638     EISSN: 18756220     Source Type: Journal    
DOI: 10.2174/1570163811666140616153436     Document Type: Article

References (167)

1. Mohanty C, Das M, Sahoo SK. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin. Expert Opin Drug Deliv 2012; 9(11): 1347-64
2. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: Problems and promises. Mol Pharm 2007; 4(6): 807-18
3. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as "Curecumin": From kitchen to clinic. Biochem Pharmacol 2008; 75(4): 787-9
4. Araujo CC, Leon LL. Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz 2001; 96: 723-28
5. Srimal RC, Dhawan BN. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 1973; 25 (6): 447-52
6. Sharma OP. Antioxidant activity of curcumin and related compounds. Biochem Pharmacol 1976; 25(15): 1811-2
7. Kuttan R, Bhanumathy P, Nirmala K, George MC. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett 1985; 29 (2): 197-2
8. Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R. Antitumour and antioxidant activity of natural curcuminoids. Cancer Lett 1995; 94 (1): 79-83
9. Sugiyama Y, Kawakishi S, Osawa T. Involvement of the betadiketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem Pharmacol 1996; 52 (4): 519-25
10. Jordan WC. Drew CR. Curcumin-A natural herb with anti- HIV activity. J Natl Med Assoc 1996; 88 (6): 333
11. Mahady GB, Pendland SL, Yun G, Lu ZZ. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Res 2002; 22 (6C): 4179-81
12. Dikshit M, Rastogi L, Shukla R, Srimal RC. Prevention of ischaemia- induced biochemical changes by curcumin & quinidine in the cat heart. Indian J Med Res 1995; 101: 31-5
13. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: A short review. Life Sci 2006; 78(18): 2081-7
14. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009; 41(1): 40-59
15. Gupta SC, Prasad S, Kim JH, et al. Multitargeting by curcumin as revealed by molecular interaction studies. Nat Prod Rep 2011; 28(12): 1937-55
16. Zhou H, Beevers CS, Huang S.. The targets of curcumin. Curr Drug Targets 2011; 12(3): 332-47
17. Romiti N, Tongiani R, Cervelli F, Chieli E. Effects of curcumin on P-glycoprotein in primary cultures of rat hepatocytes. Life Sci 1998; 62: 2349-58
18. Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, Limtrakul PN. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol 2002; 64(4): 573-82
19. Wortelboer HM, Usta M, van der Velde AE, et al. Interplay between MRP inhibition and metabolism of MRP inhibitors: The case of curcumin. Chem Res Toxicol 2003; 16: 1642-51
20. Logan-Smith MJ, Lockyer PJ, East JM, Lee AG. Curcumin, a molecule that inhibits the Ca2+-ATPase of sarcoplasmic reticulum but increases the rate of accumulation of Ca2+. J Biol Chem 2001; 276: 46905-11
21. Bilmen JG, Khan SZ, Javed MH, Michelangeli F. Inhibition of the SERCA Ca2+ pumps by curcumin. Curcumin putatively stabilizes the interaction between the nucleotide-binding and phosphorylation domains in the absence of ATP. Eur J Biochem 2001; 268: 6318-27
22. Jung Y, Xu W, Kim H, Ha N, Neckers L. Curcumin-induced degradation of ErbB2: A role for the E3 ubiquitin ligase CHIP and the Michael reaction acceptor activity of curcumin. Biochim Biophys Acta 2007; 1773: 383-90
23. Zsila F, Bikadi Z, Simonyi M. Induced circular dichroism spectra reveal binding of the antiinflammatory curcumin to human alpha1- acid glycoprotein. Bioorg Med Chem 2004; 12: 3239-45
24. Shim JS, Kim JH, Cho HY, et al. Irreversible inhibition of CD13/amino-peptidase N by the antiangiogenic agent curcumin. Chem Biol 2003; 10: 695-4
25. Began G, Sudharshan E, Appu Rao AG. Inhibition of lipoxygenase 1 by phosphatidylcholine micelles-bound curcumin. Lipids 1998; 33: 1223-28
26. Skrzypczak-Jankun E, Zhou K, McCabe NP, Selman SH, Jankun J. Structure of curcumin in complex with lipoxygenase and its significance in cancer. Int J Mol Med 2003; 12: 17-24
27. Sharma RA, Gescher AJ, Steward WP. Curcumin: The story so far. Eur J Cancer 2005; 41(13): 1955-68
28. Duan J, Zhang Y, Han S, et al. Synthesis and in vitro/in vivo anticancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles. Int J Pharm 2010; 400(1-2): 211-20
29. Shehzad A, Rehman G, Lee YS. Curcumin in inflammatory diseases. Biofactors 2013;39(1):69-77
30. Shehzad A, Wahid A, Lee YS. Curcumin in cancer chemoprevention: Molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim) 2010; 343: 489-99
31. Jurenka, JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research. Altern Med Rev 2009; 14: 141-53
32. Shehzad A, Ha T, Subhan F, Lee, YS. New mechanism and antiinflammatory role of curcumin in obesity and obesity related metabolic disease. Eur J Nutr 2011; 50: 151-61
33. Kuo JJ, Chang HH, Tsai TH, Lee TY. Positive effect of curcumin on inflammation and mitochondrial dysfunction in obese mice with liver steatosis. Int J Mol Med 2012; 30: 673-79
34. Yang F, Lim GP, Begum AN, et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 2005; 280: 5892-1
35. Kim DS, Park SY, Kim JK. Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1-42) insult. Neurosci Lett 2001; 303: 57-61
36. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM.. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 2001; 21: 8370-77
37. Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 2007; 102: 1095-4
38. Sidhu GS, Singh AK, Thaloor D, et al. Enhancement of wound healing by curcumin in animals. Wound Repair and Regeneration 1998; 6 (2): 167-77
39. Sidhu GS, Mani H, Gaddipati JP, et al. Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair and Regeneration 1999; 7 (5): 362-74
40. Mani H, Sidhu GS, Kumari R, Gaddipati JP, Seth P, Maheshwari RK. Curcumin differentially regulates TGF-β1, its receptors and nitric oxide synthase during impaired wound healing. BioFactors 2002; 16, 29-43
41. Phan TT, See P, Lee ST, Chan SY. Protective effects of curcumin against oxidative damage on skin cells in vitro: Its implication for wound healing. J Trauma 2001; 51(5):927-31
42. Jagetia GC, Rajanikant GK. Curcumin treatment enhances the repair and regeneration of wounds in mice exposed to hemibody gammairradiation. Plastic and Reconstructive Surger 2005; 115 (2): 515-28
43. Thaloor D, Singh AK, Sidhu GS, Prasad PV, Kleinman HK, Maheshwari RK. Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth and Differentiation 1998; 9 (4): 305-12
44. Arbiser JL, Klauber N, Rohan R, et al. Curcumin is an in vivo inhibitor of angiogenesis. Molecular Medicine 1998; 4 (6): 376-83
45. Mohan R, Sivak J, Ashton P, et al. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. Journal of Biological Chemistry 2000; 275 (14): 10405-12
46. Hahm ER, Gho YS, Park S, Park C, Kim KW, Yang CH. Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor- induced angiogenesis. Biochemical Biophysical Research Communication 2004; 321 (2): 337-44
47. Kim JH, Shim JS, Lee SK, et al. Microarray-based analysis of antiangiogenic activity of demethoxycurcumin on human umbilical vein endothelial cells: crucial involvement of the down-regulation of matrix metalloproteinase. Japanese Journal of Cancer Research 2002; 93 (12): 1378-85
48. Coban D, Milenkovic D, Chanet A, et al. Dietary curcumin inhibits atherosclerosis by affecting the expression of genes involved in leukocyte adhesion and transendothelial migration. Mol Nutr Food Res 2012; 56(8): 1270-81
49. Shin SK, Ha TY, McGregor RA, Choi MS. Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. Mol Nutr Food Res 2011; 55(12): 1829-40
50. Kalpana C, Rajasekharan KN, Menon VP. Modulatory effects of curcumin and curcumin analog on circulatory lipid profiles during nicotine-induced toxicity in Wistar rats. J Med Food 2005; 8(2): 246-50
51. Quiles JL, Aguilera C, Mesa MD, Ramírez-Tortosa MC, Baró L, Gil A. An ethanolic-aqueous extract of Curcuma longa decreases the susceptibility of liver microsomes and mitochondria to lipid peroxidation in atherosclerotic rabbits. Biofactors 1998; 8(1-2): 51-7
52. Quiles JL, Mesa MD, Ramirez-Tortosa CL, et al. Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits. Arterioscler Thromb Vasc Biol 2002; 22: 1225-31
53. Ramaswami G, Chai H, Yao Q, Lin PH, Lumsden AB, Chen C. Curcumin blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg 2004; 40: 1216-22
54. Parodi FE, Mao D, Ennis TL, Pagano MB, Thompson RW. Oral administration of diferuloylmethane (curcumin) suppresses proinflammatory cytokines and destructive connective tissue remodeling in experimental abdominal aortic aneurysms. Ann Vasc Surg. 2006; 20(3): 360-8
55. Li HL, Liu C, de Couto G et al. Curcumin prevents and reverses murine cardiac hypertrophy. J Clin Invest 2008 ; 118(3): 879-93
56. Morimoto T, Sunagawa Y, Kawamura T, et al. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest 2008; 118(3): 868-78
57. Misra R Sahoo SK. Coformulation of doxorubicin and curcumin in poly (D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells. Mol Pharm 2011; 8(3) :852-66
58. Ganta S, Amiji M. Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol Pharm 2009; 6(3): 928-39
59. Wang Z, Zhang Y, Banerjee S, Li Y, Sarkar FH. Notch-1 downregulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer 2006; 106(11): 2503-13
60. Subramaniam D, Ponnurangam S, Ramamoorthy P, Standing D, Battafarano RJ, Anant S, Sharma P. Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling. PLoS One 2012; 7(2): e30590
61. Rawat N, Alhamdani A, McAdam E, et al. Curcumin abrogates bile-induced NF-κB activity and DNA damage in vitro and suppresses NF-κB activity whilst promoting apoptosis in vivo, suggesting chemopreventative potential in Barrett's oesophagus. Clin Transl Oncol 2012;14(4): 302-11
62. Cai XZ, Wang J, Li XD, et al. Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression. Cancer Biol Ther 2009; 8(14): 1360-68
63. Sahu RP, Batra S, Srivastava SK. Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells. Br J Cancer 2009; 100(9): 1425-33
64. Sintara K, Thong-Ngam D, Patumraj S, Klaikeaw N. Curcumin attenuates gastric cancer induced by N-methyl-N-nitrosourea and saturated sodium chloride in rats. J Biomed Biotechnol 2012; 2012: 915380
65. He ZY, Shi CB, Wen H, Li FL, Wang BL, Wang J. Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin. Cancer Invest 2011; 29(3): 208-13
66. Huang AC, Lin SY, Su CC, et al. Effects of curcumin on N-bis(2- hydroxypropyl) nitrosamine (DHPN)-induced lung and liver tumorigenesis in BALB/c mice in vivo. In vivo 2008; 22(6): 781-5
67. Lev-Ari S, Vexler A, Starr A, et al. Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines. Cancer Invest 2007; 25(6): 411-8
68. Tian B, Wang Z, Zhao Y, et al. Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model. Cancer Lett 2008; 264(2): 299-8
69. Saini S, Arora S, Majid S, et al. Curcumin modulates microRNA- 203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev Res (Phila) 2011; 4(10): 1698-9
70. Sundram V, Chauhan SC, Ebeling M, Jaggi M. Curcumin attenuates β-catenin signaling in prostate cancer cells through activation of protein kinase D1. PLoS One 2012; 7(4): e35368
71. Yang CW, Chang CL, Lee HC, Chi CW, Pan JP, Yang WC. Curcumin induces the apoptosis of human monocytic leukemia THP-1 cells via the activation of JNK/ERK pathways. BMC Complement Altern Med 2012; 12: 22
72. Gao SM, Yang JJ, Chen CQ, Chen et al. Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells. J Exp Clin Cancer Res 2012; 31: 27
73. Zanotto-Filho A, Braganhol E, Edelweiss MI, et al. The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma. J Nutr Biochem 2012; 23(6): 591-601
74. Zhuang W, Long L, Zheng B, et al. Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy. Cancer Sci 2012; 103(4): 684-90
75. Souza CRA, Osme SF, Gloria MBA. Stability of curcuminoid pigments in model systems. J Food Process Preserv 1997; 21: 353-63
76. Tonnesen HH, Karlsen J. Studies on curcumin and curcuminoids. VI. Kinetics of curcumin degradation in aqueous solution. Z Lebensm Unters Forsch 1985; 180: 402-4
77. Oetari S, Sudibyo M, Commandeur JN, Samhoedi R, Vermeulen NP. Effects of curcumin on cytochrome P450 and glutathione-Stransferase activities in rat liver. Biochem Pharmacol 1996; 51: 39-45
78. Wang YJ, Pan MH, Cheng AL, et al.. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 1997; 15:1867-76
79. Ravindranath V, Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Toxicology 1980; 16(3): 259-65
80. Ravindranath V, Chandrasekhara N. Metabolism of curcumin- studies with [3H] curcumin. Toxicology 1981-1982; 22(4): 337-44
81. Ireson CR, Jones DJ, Orr S, et al. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 2002 11(1): 105-11
82. Yang KY, Lin LC, Tseng TY, Wang SC, Tsai TH. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 15; 853(1-2): 183-89
83. Ravindranath V, Chandrasekhara N. In vitro studies on the intestinal absorption of curcumin in rats. Toxicology 1981; 20(2-3): 251-7
84. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998; 64(4): 353-6
85. Antony B. A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95CG (Biocurcumax), A Novel Bioenhanced Preparation of Curcumin. Indian J Pharm Sc 2008; 70(4): 445-9
86. Antony B. A composition to enhance the bioavailability of curcumin. US 2007/0148263 A 1(2007)
87. Verma SP, Salamone E, Goldin B. Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides. Biochem Biophys Res Commun 1997 ;233(3): 692-6
88. Fang JY, Hung CF, Chiu HC, Wang JJ, Chan TF. Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin. J Pharm Pharmacol. 2003; 55(5): 593-1
89. Ahmad MZ, Akhter S, Jain GK, et al. Metallic nanoparticles: Technology overview & drug delivery applications in oncology. Expert Opin Drug Deliv 2010; 7(8): 927-42
90. Akhter S, Ahmad Z, Singh A, et al. Cancer targeted metallic nanoparticle: Targeting overview, recent advancement and toxicity concern. Curr Pharm Des. 2011; 17(18): 1834-50
91. Akhter S, Ahmad MZ, Ahmad FJ, Storm G, Kok RJ. Gold nanoparticles in theranostic oncology: current state-of-The-art. Expert Opin Drug Deliv 2012; 9(10): 1225-43
92. Khalil NM, do Nascimento TC, Casa DM, et al. Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats. Colloids Surf B Biointerfaces 2013 Jan 1; 101: 353-60. doi: 10.1016/j.colsurfb.2012.06.024
93. Liu L, Sun L, Wu Q, et al. Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis. Int J Pharm 2013; 443(1-2): 175-82
94. Gong C, Deng S, Wu Q, et al. Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles. Biomaterials 2013; 34(4): 1413-32
95. Wang K, Zhang T, Liu L, et al. Novel micelle formulation of curcumin for enhancing antitumor activity and inhibiting colorectal cancer stem cells. Int J Nanomedicine 2012; 7: 4487-97
96. Podaralla S, Averineni R, Alqahtani M, Perumal O. Synthesis of novel biodegradable methoxy poly(ethylene glycol)-zein micelles for effective delivery of curcumin. Mol Pharm 2012; 9(9): 2778-86
97. Raveendran R, Bhuvaneshwar G, Sharma CP. In vitro cytotoxicity and cellular uptake of curcumin-loaded Pluronic/Polycaprolactone micelles in colorectal adenocarcinoma cells. J Biomater Appl 2013; 27(7): 811-27
98. Gou M, Men K, Shi H, et al. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale 2011; 3(4): 1558-67
99. Song Z, Feng R, Sun M, Guo C, Gao Y, Li L, Zhai G. Curcuminloaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo. J Colloid Interface Sci 2011; 354(1): 116-23
100. Mohanty C, Acharya S, Mohanty AK, Dilnawaz F, Sahoo SK. Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: A novel controlled delivery vehicle for cancer therapy. Nanomedicine (Lond) 2010; 5(3): 433-49
101. Gao Y, Li Z, Sun M, et al. Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer. Drug Dev Ind Pharm 2010; 36(10): 1225-34
102. Gao Y, Li Z, Sun M, et al. Preparation and characterization of intravenously injectable curcumin nanosuspension. Drug Deliv 2011; 18(2): 131-42
103. Gao Y, Wang C, Sun M, et al. In vivo evaluation of curcumin loaded nanosuspensions by oral administration. J Biomed Nanotechnol 2012; (4): 659-68
104. Wei XL, Han YR, Quan LH, Liu CY, Liao YH. Oily nanosuspension for long-acting intramuscular delivery of curcumin didecanoate prodrug: Preparation, characterization and in vivo evaluation. Eur J Pharm Sci 2013; 49(2): 286-93
105. Noack A, Hause G, Mäder K. Physicochemical characterization of curcuminoid-loaded solid lipid nanoparticles. Int J Pharm 2012; 423(2): 440-51
106. Yan YD, Kim JA, Kwak MK, et al. Enhanced oral bioavailability of curcumin via a solid lipid-based self-emulsifying drug delivery system using a spray-drying technique. Biol Pharm Bull 2011; 34(8): 1179-86
107. Sou K, Inenaga S, Takeoka S, Tsuchida E. Loading of curcumin into macrophages using lipid-based nanoparticles. Int J Pharm 2008; 352(1-2): 287-93
108. Wang W, Zhu R, Xie Q, et al. Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int J Nanomedicine 2012; 7: 3667-77
109. Fang M, Jin Y, Bao W, et al. In vitro characterization and in vivo evaluation of nanostructured lipid curcumin carriers for intragastric administration. Int J Nanomedicine 2012; 7: 5395-4
110. Mulik RS, Mönkkönen J, Juvonen RO, Mahadik KR, Paradkar AR. Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis. Int J Pharm 2010; 398(1-2): 190-3
111. Yadav VR, Suresh S, Devi K, Yadav S. Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and antiinflammatory activity for optimization of therapy of inflammatory bowel disease. J Pharm Pharmacol 2009; 61(3): 311-21
112. Nayak AP, Tiyaboonchai W, Patankar S, Madhusudhan B, Souto EB. Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment. Colloids Surf B Biointerfaces 2010; 81(1): 263-73
113. Sutaria D, Grandhi BK, Thakkar A, Wang J, Prabhu S. Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen. Int J Oncol 2012; 41(6): 2260-68
114. Kakkar V, Mishra AK, Chuttani K, Kaur IP. Proof of concept studies to confirm the delivery of curcumin loaded solid lipid nanoparticles (c-slns) to brain. Int J Pharm 2013; 448(2): 354-9
115. Kakkar V, Singh S, Singla D, Kaur IP. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol Nutr Food Res 2011; 55(3): 495-3
116. Kakkar V, Muppu SK, Chopra K, Kaur IP. Curcumin loaded solid lipid nanoparticles: An efficient formulation approach for cerebral ischemic reperfusion injury in rats. Eur J Pharm Biopharm. 2013; 85(3 Pt A): 339-45
117. Kakkar V, Kaur IP. Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain. Food Chem Toxicol 2011; 49(11): 2906-13
118. Bisht S, Feldmann G, Soni S, Ravi R, Karikat C, Maitra A. Polymetric nanoparticle-encapsulated curcumin ("nanocurcumin"): A novel strategy for human cancer therapy. Nanobiotechnolgy 2007; 5: 3
119. Feng R, Song Z, Zhai G. Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles. Int J Nanomedicine 2012; 7: 4089-98
120. Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MN. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 2009; 37(3-4): 223-30
121. Rejinold NS, Sreerekha PR, Chennazhi KP, Nair SV, Jayakumar R. Biocompatible, biodegradable and thermo-sensitive chitosan-gpoly (N-isopropylacrylamide) nanocarrier for curcumin drug delivery. Int J Biol Macromol 2011; 49(2): 161-72
122. Rejinold NS, Muthunarayanan M, Divyarani VV, et al. Curcuminloaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery. J Colloid Interface Sci 2011; 360(1): 39-51
123. Rejinold NS, Muthunarayanan M, Chennazhi KP, Nair SV, Jayakumar R. Curcumin loaded fibrinogen nanoparticles for cancer drug delivery. J Biomed Nanotechnol 2011; 7(4): 521-34
124. Jithan A, Madhavi K, Madhavi M, Prabhakar K. Preparation and characterization of albumin nanoparticles encapsulating curcumin intended for the treatment of breast cancer. Int J Pharm Investign 2011; 1(2): 119-25
125. Shao J, Zheng D, Jiang Z, et al. Curcumin delivery by methoxy polyethylene glycol-poly(caprolactone) nanoparticles inhibits the growth of C6 glioma cells. Acta Biochim Biophys Sin (Shanghai) 2011; 43(4): 267-74
126. de Souza FF, dos Santos MC, dos Passos DC, Lima EC, Guillo LA. Curcumin associated magnetite nanoparticles inhibit in vitro melanoma cell growth. J Nanosci Nanotechnol 2011; 11(9): 7603-10
127. Yallapu MM, Othman SF, Curtis ET, et al. Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications. Int J Nanomedicine. 2012; 7: 1761-79
128. Dilnawaz F, Singh A, Sahoo SK. Transferrin-conjugated curcuminloaded superparamagnetic iron oxide nanoparticles induce augmented cellular uptake and apoptosis in K562 cells. Acta Biomater 2012; 8(2): 704-19
129. Mulik RS, Monkkonen J, Juvonen RO, Mahadik KR, Paradkar AR. ApoE3 mediated polymeric nanoparticles containing curcumin: Apoptosis induced in vitro anticancer activity against neuroblastoma cells. Int J Pharm 2012; 437(1-2): 29-41
130. Alam S, Panda JJ, Chauhan VS. Novel dipeptide nanoparticles for effective curcumin delivery. Int J Nanomedicine 2012; 7: 4207-22
131. Punfa W, Yodkeeree S, Pitchakarn P, Ampasavate C, Limtrakul P. Enhancement of cellular uptake and cytotoxicity of curcuminloaded PLGA nanoparticles by conjugation with anti-Pglycoprotein in drug resistance cancer cells. Acta Pharmacol Sin 2012; 33(6): 823-31
132. Nair KL, Thulasidasan AK, Deepa G, Anto RJ, Kumar GS. Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier. Int J Pharm 2012; 425(1-2): 44-52
133. Ghosh D, Choudhury ST, Ghosh S, et al. Nanocapsulated curcumin: oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat. Chem Biol Interact 2012; 195(3): 206-14
134. Manju S, Sreenivasan K. Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells. J Colloid Interface Sci 2012; 368(1): 144-51
135. Zhou N, Zan X, Wang Z, et al. Galactosylated chitosanpolycaprolactone nanoparticles for hepatocyte-targeted delivery of curcumin. Carbohydr Polym 2013; 94(1): 420-9
136. Yin HT, Zhang DG, Wu XL, Huang XE, Chen G. In vivo Evaluation of Curcumin-loaded Nanoparticles in a A549 Xenograft Mice Model. Asian Pac J Cancer Prev 2013; 14(1): 409-12
137. El-Sherbiny IM, Smyth HD. In situ synthesis and surface functionalization of gold nanoparticles with curcumin and their antioxidant properties: An experimental and density functional theory investigation. Nanoscale 2013; 5(5): 1882-93
138. Yadav A, Lomash V, Samim M, Flora SJ. Curcumin encapsulated in chitosan nanoparticles: A novel strategy for the treatment of arsenic toxicity. Chem Biol Interact 2012; 199(1): 49-61
139. Cutrin JC, Geninatti Crich S, Burghelea D, Dastrù W, Aime S. Curcumin/Gd loaded Apoferritin: A novel "theranostic" agent to prevent hepatocellular damage in toxic induced acute hepatitis. Mol Pharm 2013; 10(5): 2079-85
140. Cheng KK, Yeung CF, Ho SW, Chow SF, Chow AH, Baum L. Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease tg2576 mice. AAPS J. 2013; 15(2): 324-36
141. Mathew A, Fukuda T, Nagaoka Y, et al. Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease. PLoS One 2012; 7(3): e32616
142. Gandapu U, Chaitanya RK, Kishore G, Reddy RC, Kondapi AK. Curcumin-loaded apotransferrin nanoparticles provide efficient cellular uptake and effectively inhibit HIV-1 replication in vitro. PLoS One 2011; 6(8): e23388
143. Huang Q, Yu H, Ru Q. Bioavailability and delivery of neutraceuticals using nanotechnology. J Food Sci 2011; 75: R50-7
144. Onoue S, Takahashi H, Kawabata Y, et al. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. J Pharm Sci 2010; 99(4): 1871- 81
145. Ganta S, Devalapally H, Amiji M. Curcumin enhances oral bioavailability and anti-tumor therapeutic efficacy of paclitaxel upon administration in nanoemulsion formulation. J Pharm Sci 2010; 99(11): 4630-41
146. Yu H, Huang Q. Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions. J Agric Food Chem 2012; 60(21): 5373-79
147. Kumar A, Ahuja A, Ali J, Baboota S. Curcumin loaded nano globules for solubility enhancement: Preparation, characterization and ex vivo release study. J Nanosci Nanotechnol 2012; 12(11): 8293-2
148. Anuchapreeda S, Fukumori Y, Okonogi S, Ichikawa H. Preparation of Lipid Nanoemulsions Incorporating Curcumin for Cancer Therapy. J Nanotech 2012 doi:10.1155/2012/270383
149. Li L, Braiteh FS, Kurzrock R. Liposome-encapsulated curcumin: In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 2005; 104(6): 1322-31
150. Li L, Ahmed B, Mehta K, Kurzrock R. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol Cancer Ther 2007; 6(4): 1276-82
151. Narayanan NK, Nargi D, Randolph C, Narayanan BA. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int J Cancer 2009; 125(1): 1-8
152. Wang H, Hu L, Li C, Zhang J, Zhang T. Increase of therapeutic activity of doxorubicin by long circulating liposomes in combination with curcumin. Pharmazie 2011; 66(11): 871-74
153. Lu Y, Ding N, Yang C, Huang L, Liu J, Xiang G. Preparation and in vitro evaluation of a folate-linked liposomal curcumin formulation. J Liposome Res 2012; 22(2): 110-9
154. Orr WS, Denbo JW, Saab KR, et al. Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factorkappa B inhibition. Surgery 2012; 151(5): 736-44
155. Dhule SS, Penfornis P, Frazier T, et al. Curcumin-loaded β- cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomedicine 2012; 8(4): 440-51
156. Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanoformulations: A future nanomedicine for cancer. Drug Discov Today 2012; 17(1- 2): 71-80
157. Dandekar PP, Jain R, Patil S, et al. Curcumin-loaded hydrogel nanoparticles: Application in anti-malarial therapy and toxicological evaluation. J Pharm Sci 2010; 99(12): 4992-10
158. Vimala K, Mohan YM, Varaprasad K, et al. Fabrication of curcumin encapsulated chitosan-PVA silver nanocomposite films for improved antimicrobial activity. J Biomaterials Nanobiotechnol 2011; 2(1): 55-64
159. Ravindra S, Mulaba-Bafubiandi AF, Rajinikanth V, Varaprasad K, Reddy NN, Raju K M. Development and Characterization of Curcumin Loaded Silver Nanoparticle Hydrogels for Antibacterial and Drug Delivery Applications. J Inorganic Organometallic Polymers Materials 2012; 22(6): 1254-62
160. Li X, Chen S, Zhang B, et al. In situ injectable nano-composite hydrogel composed of curcumin, N,O-carboxymethyl chitosan and oxidized alginate for wound healing application. Int J Pharm 2012; 437(1-2): 110-9
161. Altunbas A, Lee SJ, Rajasekaran SA, Schneider JP, Pochan DJ. Encapsulation of curcumin in self-assembling peptide hydrogels as injectable drug delivery vehicles. Biomaterials 2011; 32(25): 5906-14
162. Chen X, Zhi F, Jia X, et al. Enhanced brain targeting of curcumin by intranasal administration of a thermosensitive poloxamer hydrogel. J Pharm Pharamacol 2013; 65(6): 807-16
163. Shpaisman N, Sheihet L, Bushman J, Winters J, Kohn J. One-step synthesis of biodegradable curcumin-derived hydrogels as potential soft tissue fillers after breast cancer surgery. Biomacromolecules 2012; 13(8): 2279-86
164. Goodpasture CE, Arrighi FE. Effects of food seasonings on the cell cycle and chromosome morphology of mammalian cells in vitro with special reference to turmeric. Food Cosmet Toxicol 1976; 14: 9-14
165. Cao J. Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells. Toxicol Sci 2006; 91: 476-83
166. National Toxicology Program. NTP Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1) (Major Component 79%-85% Curcumin, CAS No. 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies). Natl Toxicol Program Tech Rep Ser 1993; 427: 1-275
167. Dance-Barnes ST. Lung tumor promotion by curcumin. Carcinogenesis 2009; 30: 1016-23.